A crucial molecular determinant of the malignant behaviour of breast cancer, and in particular of the metastasizing capacity, is the p63 transcriptional target gene SHARP1 (known also as DEC2 or BHLHE41) that, in triple breast cancer, results in a very negative prognostic fate [74]. This evidence concerns the gene BHLHE41 and breast cancer.